AZO COMPOUND, CURABLE COMPOSITION, COLOR FILTER, AND METHOD OF PRODUCING THE SAME
申请人:MIZUKAWA Yuki
公开号:US20090075188A1
公开(公告)日:2009-03-19
This invention provides an azo compound represented by Formula (I), Formula (II), or Formula (III):
wherein R
1
and R
2
each independently represent a hydrogen atom or a substituent; D
1
and D
2
each independently represent a coupler residue; Z
1
and Z
2
each independently represent —C(R
3
)═ or —N═; and R
3
represents a hydrogen atom or a substituent.
This invention relates to iminodiacetic acid and diamine hydroxamic acid derivatives, that are inhibitors of histone deacetylase (HDAC), and are useful in the prevention and/or treatment of cellular proliferative diseases, for example cancer, autoimmune, allergic and inflammatory diseases, diseases of the central nervous system (CNS) such as neurodegenerative diseases, and in the prevention and/or treatment of restenosis.
Dubsky; Blumer, Chemische Berichte, 1919, vol. 52, p. 216
作者:Dubsky、Blumer
DOI:——
日期:——
FORMATION AND USES OF EUROPIUM
申请人:WAYNE STATE UNIVERSITY
公开号:US20160022842A1
公开(公告)日:2016-01-28
An MRI contrast composition includes a liposome and a europium metal complex disposed within the liposome. The europium metal complex includes a europium metal ion and a multi-dentate ligand selected from the group consisting of cryptands and thiacryptands and one or more counter-ions that balances a charge of the europium metal ion and the multi-dentate ligand, the europium metal ion being switchable between a 2+ and 3+ oxidation state. The contrast composition advantageously provides an oxidation-responsive dual-mode contrast agent because it would enhance either T
1
-weighted images or CEST images depending on the oxidation state of Eu.